Biotechnology Innovation Organization· @IAmBiotech · X·· 3 小时前AI 评分18
AI 导读
CDKL5 缺乏症导致婴儿期起病的严重癫痫发作，目前尚无获批疗法针对其潜在生物学机制。BrainStorm Therapeutics 是 #BIO2026 种子阶段创业竞技场的获胜者，正在开发一款此类疗法。阅读更多：https://bio.news/bio-convention/brainstorm-therapeutics-combines-brain-organoids-and-ai-for-cns-drug-discovery/
正文
CDKL5 deficiency disorder causes severe seizures beginning in infancy, and no approved therapy addresses its underlying biology. BrainStorm Therapeutics, the Seed-Stage Start-Up Stadium winner at #BIO2026, is developing one. Read more: https://bio.news/bio-convention/brainstorm-therapeutics-combines-brain-organoids-and-ai-for-cns-drug-discovery/
来源：Biotechnology Innovation Organization · x.com